flusoxolol has been researched along with atenolol in 2 studies
*Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. [MeSH]
*Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaber, LC; Bradshaw, RM; Burden, DT; Fryer, AD; Hurst, DN; Machin, PJ; Melarange, RA; Shivdasani, C | 1 |
| Arnold, JM; Brown, AN; Finch, MB; Francis, RJ; Galloway, DB; Harron, DW; McDevitt, DG; O'Connor, PC; Shanks, RG | 1 |
1 trial(s) available for flusoxolol and atenolol
| Article | Year |
|---|---|
Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Double-Blind Method; Half-Life; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Kinetics; Male; Phenoxypropanolamines; Physical Exertion; Propanolamines; Random Allocation; Regional Blood Flow; Time Factors | 1985 |
1 other study(ies) available for flusoxolol and atenolol
| Article | Year |
|---|---|
beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines.
Topics: Adrenergic beta-Agonists; Animals; Biological Assay; Blood Pressure; Heart Rate; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Phenyl Ethers; Propanolamines; Rats; Structure-Activity Relationship | 1983 |